Letters, Testimony & Comments

July 2, 2004
Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment.
July 2, 2004
Development and Use of Risk Minimization Action Plans.
July 2, 2004
Premarketing Risk Assessment.
July 1, 2004
In response to §1013 of the Medicare Prescription Drug, Improvement, and Modernization Act.
June 24, 2004
at the Global Public Policy Institute and Ecole de Science Politique
June 7, 2004
Dear Majority Leader Frist: We, the undersigned biotechnology executives, strongly oppose further efforts to legalize prescription drug importation. Importation will put patients at risk, chill investment in biotechnology and other...
June 1, 2004
Re: Docket No. 2004N-0115 Request for Comment on Prescription Drug Importation Dear Dr. Carmona and Members of the HHS Task Force on Importation: The Biotechnology Industry Organization (BIO) submits the following comments in response to the...
May 26, 2004
On behalf of the Biotechnology Industry Organization (BIO), please accept this letter in support of Senate Bill 74, a bill that would prohibit reproductive human cloning in Louisiana. We understand the Committee on Health & Welfare will...
May 26, 2004
Supporting Senate Bill 74, which would preserve therapeutic cloning research in the state (May 26, 2004).
May 24, 2004
The Honorable Judd Gregg Chairman Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 The Honorable Edward Kennedy Ranking Member Committee on Health, Education, Labor and Pensions...
May 20, 2004
TESTIMONY OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION BEFORE THE COMMITTEE ON HEALTH, EDUCATION, LABOR, & PENSIONS OF THE UNITED STATES SENATE IMPORTATION OF PRESCRIPTION DRUGS MAY 20, 2004 The Biotechnology Industry Organization (...
May 19, 2004
In opposition to New York Senate Bill 6537, which proposes to prohibit the sale of "transgenic aquatic animals" (May 19, 2004).
May 19, 2004
Pharmacovigilance Planning (PvP).
May 16, 2004
On Conflict of Interest Policies
May 11, 2004
May 11, 2004 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, Maryland 20857 Re: Docket No. 2004N-0087, Federal Register March 3, 2004 (Volume 69, Number 42, Page 9982) "...